Home > Boards > US Listed > Medical - Drugs >

Nektar Therapeutics (NKTR)

NKTR RSS Feed
Add NKTR Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 1/15/2020 4:41:09 PM - Followers: 36 - Board type: Free - Posts Today: 0

http://www.nektar.com

http://finance.yahoo.com/q?s=NKTR


Nektar Therapeutics, a biopharmaceutical company, develops various drug products and product candidates using its proprietary drug delivery technologies. Its technology platforms comprise PEGylation Technology designed to enhance the performance of various drug classes, including macromolecules, small molecules, and other drugs; and Pulmonary Technology, which includes technologies for drug formulation, powder processing, powder filling, and packaging, as well as dry powder inhaler devices and liquid nebulizer devices. The company's technologies are used in 10 approved products; 3 partner programs that have been filed for with the FDA; and 12 development programs in human clinical trials. Its partnered products include Tobramycin inhalation powder, a Phase III clinical product for treating lung infections; NKTR-061, a Phase II clinical product for gram-negative pneumonias; Ciprofloxacin Inhalation Powder, a Phase II clinical product for lung infections; Pulmonary dronabinol, a Phase II product for migraine; and Exubera Inhalation Powder for adult type 1 and type 2 diabetes. The company's partnered product portfolio also comprises Neulasta for neutropenia; PEGASY for Hepatitis-C; Somavert for Acromegaly; PEG-INTRON for Hepatitis-C; Macugen for age-related macular degeneration; CIMZIA for Crohn's disease; MIRCERA for renal anemia and chronic kidney disease; CIMZIA for rheumatoid arthritis; Hematide, a Phase III product for Anemia; Macugen, a Phase II clinical trial product for diabetic macular edema and retinal vein occlusion; and CDP 791, a Phase II product for nonsmall cell lung cancer. In addition, Nektar's proprietary products include NKTR-102, a Phase II trial product for colorectal cancer; and NKTR-118, which is in Phase II clinical trials for opioid-induced constipation and other manifestations of opioid bowel dysfunction. The company was founded in 1990 and is headquartered in San Carlos, California.


NKTR
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NKTR News: Nektar Therapeutics to Webcast Presentation at the Cowen and Company 40th Annual Health Care Conference 02/28/2020 06:30:00 PM
NKTR News: Nektar Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results 02/27/2020 04:15:00 PM
NKTR News: Statement of Changes in Beneficial Ownership (4) 02/20/2020 06:40:29 PM
NKTR News: Statement of Changes in Beneficial Ownership (4) 02/20/2020 06:39:39 PM
NKTR News: Statement of Changes in Beneficial Ownership (4) 02/20/2020 06:38:54 PM
PostSubject
#260   * * $NKTR Video Chart 01-15-2020 * * ClayTrader 01/15/20 04:41:09 PM
#259   Comments on the JPM webcast: #msg-153299506. DewDiligence 01/14/20 07:45:04 PM
#258   We talk about NKTR a little on #board-1418. DewDiligence 01/11/20 02:02:59 PM
#257   On what board are people discussing Nektar ? Sluicebox 01/11/20 07:21:58 AM
#256   Yea, bloody taa for !? I will check back. czni 12/14/19 05:36:02 PM
#255   Well if that wasn’t the strangest thing on czni 12/14/19 05:27:37 PM
#254   I have been doing a lot of studying czni 12/14/19 05:11:12 PM
#253   You saw that, yes. thanks but I do not czni 12/14/19 05:04:15 PM
#252   That’s why I love this board. You don’t czni 12/14/19 05:01:16 PM
#251   Hey gang, Im a quiet holder but have a czni 12/14/19 04:53:54 PM
#250   Thinking people are just taking profits today? Clemdane 12/11/19 11:44:37 AM
#249   News: $NKTR 2 Stocks That Soared Monday While whytestocks 12/09/19 10:45:23 PM
#248   News: $NKTR Why Nektar Therapeutics Stock Popped Today whytestocks 12/09/19 07:15:33 PM
#247   News: $NKTR Nektar Therapeutics Announces Presentation of New whytestocks 12/09/19 06:30:32 PM
#246   News: $NKTR Nektar Therapeutics Presents Data from First-in-Human whytestocks 11/10/19 11:15:26 AM
#245   News: $NKTR Nektar Therapeutics Presents New Clinical and whytestocks 11/09/19 06:04:24 PM
#244   * * $NKTR Video Chart 10-08-2019 * * ClayTrader 10/08/19 06:05:06 PM
#243   Everything You Need For Your Premarket Including Nektar behindthebid 08/09/19 08:58:48 AM
#242   NKTR says two production lots of NKTR-214 were DewDiligence 08/08/19 05:20:19 PM
#241   Hmm… https://finance.yahoo.com/news/nektar-therapeutics-reports-financial-res DewDiligence 08/08/19 04:25:02 PM
#240   A trial in Germany is testing a neoantigen jondoeuk 08/06/19 04:54:47 PM
#239   News: $NKTR Nektar Therapeutics and Bristol-Myers Squibb Announce whytestocks 08/01/19 04:50:28 PM
#238   NKTR 4Q18 CC transcript: DewDiligence 03/01/19 09:42:01 AM
#237   ASCO-SITC Clinical Immuno-Oncology Symposium abstract jondoeuk 02/25/19 05:35:40 PM
#236   Dr. Zalevsky will provide updates on NKTR-214 during jondoeuk 12/29/18 03:43:05 PM
#235   From this: ''With NKTR-214, a kinetically engineered IL-2 jondoeuk 11/25/18 03:58:37 PM
#234   SITC data—Melanoma PIVOT-02 ORR=53%* (20*/38)—24% (9/38) CRs: DewDiligence 11/09/18 06:46:10 PM
#233   I had a few too many. What I jondoeuk 11/08/18 12:30:16 PM
#232   NKTR 3Q18 results—cash=$2.0B: DewDiligence 11/07/18 06:45:02 PM
#231   NKTR 3Q18 results—cash=$353M: DewDiligence 11/07/18 04:41:37 PM
#230   NKTR, PFE ink clinical-trial collaboration for NKTR-214 with DewDiligence 11/06/18 09:29:43 AM
#229   You own ONCS because of management? DewDiligence 11/03/18 06:42:21 PM
#228   $GNCA*, $ONCS*, $GRTS, $REPL, $DVAX, $ADRO** and $IDRA*** jondoeuk 11/03/18 06:25:34 PM
#226   Which biotech companies are you long? TIA DewDiligence 10/27/18 06:40:01 PM
#225   Melanoma Bridge Conference: 'Immune monitoring after NKTR-214 plus jondoeuk 10/27/18 06:14:43 PM
#224   Appears that institutions have made up their mind tigerpac 10/24/18 11:47:29 AM
#223   On second thought, #msg-144383492 is a better explanation DewDiligence 10/22/18 04:01:52 PM
#222   My take, FWIW: #msg-144374334. DewDiligence 10/22/18 11:24:28 AM
#221   The shareholder is always the last one to tigerpac 10/22/18 11:16:57 AM
#220   After examining the "rebuttal" text more closely, I'm DewDiligence 10/04/18 08:30:55 PM
#219   If that's a real email response from the DewDiligence 10/04/18 03:09:32 PM
#218   Someone emailed the IR department and posted the jondoeuk 10/04/18 10:34:45 AM
#217   3 different posters on the NKTR YMB "Conversations" stockbettor 10/04/18 09:22:13 AM
#216   Where is that from? DewDiligence 10/03/18 06:58:23 PM
#215   This is the company's response to the short jondoeuk 10/03/18 03:46:04 PM
#214   Related info: #msg-136150360. DewDiligence 09/27/18 07:29:14 PM
#213   A neoantigen vaccine (VB10.NEO) and 214 will be jondoeuk 09/27/18 06:52:50 PM
#212   15% drop this week. Me thinks something not tigerpac 09/14/18 10:11:59 AM
#211   The CC was routine. A lot of clinical DewDiligence 08/10/18 10:30:52 AM
#210   Nothing negative from last earning report....stock back on tigerpac 08/10/18 09:48:27 AM
PostSubject